BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20853354)

  • 21. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre.
    Kenny D; Morgan G; Bajwa A; Farrow C; Parry A; Caputo M; Tometzki A; Martin R
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):568-75. PubMed ID: 19235245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplatzer Septal Occluder to treat iatrogenic cardiac perforations.
    Stolt V; Cook S; Räber L; Wani S; Garachamani A; Vogel R; Seiler C; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):263-70. PubMed ID: 22131255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which patients might be suitable for a septal occluder device closure of postinfarction ventricular septal rupture rather than immediate surgery?
    Attia R; Blauth C
    Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):626-9. PubMed ID: 20621996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous closure of paravalvular leak and ventricular septum defect.
    Smolka G; Pysz P; Ochała A
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):326-30. PubMed ID: 21766422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wire fractures in Solysafe septal occluders: a single center experience.
    Gielen S; Riede FT; Schuler G; Dähnert I
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1161-8. PubMed ID: 22105791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder.
    Knepp MD; Rocchini AP; Lloyd TR; Aiyagari RM
    Congenit Heart Dis; 2010; 5(1):32-7. PubMed ID: 20136855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late complete atrioventricular block and tricuspid regurgitation after percutaneous closure of a perimembranous ventricular septal defect.
    Chen H; Liu J; Gao W; Hong H
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):e60-1. PubMed ID: 20643421
    [No Abstract]   [Full Text] [Related]  

  • 28. Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.
    Crawford GB; Brindis RG; Krucoff MW; Mansalis BP; Carroll JD
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):157-67. PubMed ID: 22552868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter closure of a traumatic ventricular septal defect using an Amplatzer™ atrial septal occluder device.
    Ali TA; Fatimi SH; Hasan BS
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):569-73. PubMed ID: 23483660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Amplatzer vascular plug and Amplatzer vascular plug II for vascular occlusion procedures in 50 patients with congenital cardiovascular disease.
    Schwartz M; Glatz AC; Rome JJ; Gillespie MJ
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):411-7. PubMed ID: 20552654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late erosion of an Amplatzer septal occluder device 6 years after placement.
    Taggart NW; Dearani JA; Hagler DJ
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):221-2. PubMed ID: 21463878
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: a case series.
    Goldstein JA; Casserly IP; Balzer DT; Lee R; Lasala JM
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):238-43. PubMed ID: 12772250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A monocenter experience of ventricular septal defects treated by catherization].
    Paoli F; Dragulescu A; Amedro P; Ovaert C; Mas B; Ghez O; Metras D; Kreitmann B; Fraisse A
    Arch Mal Coeur Vaiss; 2007 May; 100(5):380-5. PubMed ID: 17646761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter closure of high-risk muscular ventricular septal defects with the CardioSEAL occluder: initial report from the CardioSEAL VSD registry.
    Lim DS; Forbes TJ; Rothman A; Lock JE; Landzberg MJ
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):740-4. PubMed ID: 17621665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrograde percutaneous closure of a ventricular septal defect after myectomy for hypertrophic obstructive cardiomyopathy.
    Singh V; Badheka AO; Bokhari SS; Ghersin E; Clark PM; O'Neill WW
    Tex Heart Inst J; 2013; 40(4):468-71. PubMed ID: 24082382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder.
    Qin Y; Chen J; Zhao X; Liao D; Mu R; Wang S; Wu H; Guo H
    Am J Cardiol; 2008 Jun; 101(12):1781-6. PubMed ID: 18549859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution in the management of postinfarct ventricular septal defects from surgical to percutaneous approach: a single-center experience.
    Sathananthan J; Ruygrok P
    J Invasive Cardiol; 2013 Jul; 25(7):339-43. PubMed ID: 23813062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Device closure of congenital ventricular septal defects.
    Diab KA; Cao QL; Hijazi ZM
    Congenit Heart Dis; 2007; 2(2):92-103. PubMed ID: 18377484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.
    Szkutnik M; Kusa J; Białkowski J
    Kardiol Pol; 2008 Sep; 66(9):941-7; discussion 948-9. PubMed ID: 18924021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous closure of post-traumatic and congenital muscular ventricular septal defects with the Amplatzer Muscular VSD Occluder.
    Szkutnik M; Kusa J; Białkowski J
    Kardiol Pol; 2008 Jul; 66(7):715-20; discussion 721. PubMed ID: 18690562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.